PPD is a contract research organization for delivering life-changing therapies.
PPD is a contract research organization providing discovery, development, and post-approval services as well as compound partnering programs. Their clients and partners include pharmaceutical, biotechnology, medical devices, academic, and government organizations. They apply innovative technologies, therapeutic expertise, and a firm commitment to quality to help customers bend the cost and time curve of drug development to provide life-changing therapies that improve health.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Oct 7, 2021
Science 37
|
Post-IPO Equity | $200M | Biotechnology | — |
Aug 20, 2020
Science 37
|
Series Unknown | $40M | Biotechnology | Yes |
Jan 3, 2019
Science 37
|
Series D | $35M | Biotechnology | Yes |